Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
1.72
Dollar change
-0.02
Percentage change
-1.15
%
IndexRUT P/E- EPS (ttm)-1.78 Insider Own13.44% Shs Outstand67.89M Perf Week2.38%
Market Cap117.41M Forward P/E- EPS next Y-1.37 Insider Trans0.00% Shs Float59.08M Perf Month-5.49%
Income-120.23M PEG- EPS next Q-0.42 Inst Own75.63% Short Float6.22% Perf Quarter-14.00%
Sales0.00M P/S- EPS this Y8.19% Inst Trans1.19% Short Ratio11.75 Perf Half Y-2.27%
Book/sh1.80 P/B0.95 EPS next Y14.73% ROA-54.09% Short Interest3.68M Perf Year-61.35%
Cash/sh1.57 P/C1.09 EPS next 5Y- ROE-68.07% 52W Range1.62 - 5.70 Perf YTD-23.56%
Dividend Est.- P/FCF- EPS past 5Y-73.43% ROI-78.17% 52W High-69.82% Beta-0.20
Dividend TTM- Quick Ratio8.46 Sales past 5Y0.00% Gross Margin- 52W Low6.17% ATR (14)0.12
Dividend Ex-Date- Current Ratio8.46 EPS Y/Y TTM17.22% Oper. Margin0.00% RSI (14)44.21 Volatility6.81% 6.67%
Employees168 Debt/Eq0.28 Sales Y/Y TTM- Profit Margin- Recom1.25 Target Price14.06
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q-5.52% Payout- Rel Volume0.46 Prev Close1.74
Sales Surprise- EPS Surprise-19.11% Sales Q/Q- EarningsMay 09 AMC Avg Volume313.04K Price1.72
SMA20-2.13% SMA50-9.02% SMA200-20.46% Trades Volume143,408 Change-1.15%
Date Action Analyst Rating Change Price Target Change
Jul-26-22Initiated Wedbush Outperform $18
Apr-27-22Initiated Goldman Neutral $6
Dec-17-21Initiated H.C. Wainwright Buy $26
Dec-03-21Initiated Robert W. Baird Outperform $38
Dec-02-21Initiated Oppenheimer Outperform $30
Oct-19-21Initiated JMP Securities Mkt Outperform $40
Mar-25-21Initiated B. Riley Securities Buy $60
Mar-03-21Initiated Evercore ISI Outperform $48
Mar-03-21Initiated Barclays Overweight $56
Mar-02-21Initiated Stifel Buy $58
May-13-24 09:22AM
May-09-24 10:54PM
04:05PM
May-06-24 08:00AM
May-03-24 04:01PM
04:01PM Loading…
May-02-24 04:01PM
Apr-04-24 08:32AM
Apr-01-24 08:00AM
Mar-20-24 09:53PM
04:05PM
Mar-05-24 04:01PM
Mar-04-24 08:00AM
Feb-15-24 02:56PM
Feb-07-24 08:00AM
Feb-02-24 04:01PM
08:22AM Loading…
Jan-19-24 08:22AM
Jan-17-24 04:01PM
Dec-21-23 04:01PM
Dec-01-23 04:01PM
Nov-27-23 08:00AM
Nov-09-23 04:01PM
Nov-07-23 04:05PM
Nov-03-23 04:01PM
08:00AM
Nov-02-23 09:01AM
Oct-03-23 04:01PM
Sep-25-23 08:00AM
Aug-30-23 08:00AM
Aug-10-23 04:05PM
Aug-01-23 08:00AM
04:03PM Loading…
Jun-09-23 04:03PM
07:30AM
Jun-05-23 08:00AM
May-11-23 04:05PM
Apr-19-23 02:42PM
Apr-18-23 08:00AM
Mar-28-23 09:55AM
Mar-23-23 04:01PM
Mar-07-23 05:52AM
Feb-21-23 08:00AM
Feb-16-23 02:04PM
12:00PM
Jan-19-23 08:00AM
Jan-12-23 08:00AM
Dec-16-22 06:40PM
Dec-07-22 07:45AM
07:30AM
Nov-30-22 10:35AM
Nov-22-22 08:00AM
Nov-10-22 04:15PM
Nov-01-22 08:00AM
Oct-14-22 10:26AM
Oct-12-22 08:00AM
Oct-11-22 08:00AM
Sep-28-22 08:00AM
Sep-06-22 04:15PM
Sep-01-22 09:55AM
Aug-16-22 09:55AM
Aug-11-22 04:15PM
Aug-01-22 08:00AM
Jun-10-22 08:00AM
Jun-01-22 08:00AM
May-12-22 04:15PM
May-07-22 09:20AM
May-05-22 08:00AM
Apr-25-22 08:00AM
Apr-14-22 04:15PM
Mar-22-22 10:10AM
Mar-14-22 04:30PM
Feb-28-22 08:00AM
Feb-11-22 08:00AM
Jan-04-22 08:00AM
Nov-29-21 08:00AM
Nov-25-21 07:35AM
Nov-19-21 04:01PM
11:48AM
Nov-15-21 10:39AM
Nov-11-21 12:51PM
Nov-10-21 04:10PM
Nov-09-21 08:30AM
Nov-08-21 08:00AM
Nov-04-21 09:15AM
Oct-19-21 07:00AM
Oct-12-21 08:00AM
Sep-09-21 08:00AM
Sep-02-21 08:00AM
Aug-09-21 04:05PM
Jul-08-21 08:00AM
Jun-17-21 08:00AM
Jun-11-21 08:00AM
Jun-10-21 08:00AM
May-25-21 04:10PM
May-07-21 10:30AM
May-06-21 04:08PM
Apr-28-21 08:00AM
Mar-25-21 04:35PM
Mar-05-21 03:00PM
Mar-01-21 03:45PM
Feb-09-21 04:05PM
Feb-05-21 06:50AM
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.